Albireo and Genpharm Announce Agreement to Commercialize Bylvay™ (odevixibat) in Saudi Arabia and the Gulf Region
– Bylvay is approved in the U.S. and EU as only once-daily drug indicated for patients with PFIC – PFIC is a life-threatening liver disease and the